#2079 - Brigham Buhler
Brigham Buhler is the founder of Ways2Well, a functional and regenerative care clinic, and a cofounder of its sister company, ReviveRx: a pharmacy focusing on health, wellness, and restorative medicine.
Episodes with Brigham Buhler
Categories
Key Takeaways
The historical context of pharmaceutical practices reveals troubling patterns.
Understanding past misconduct helps in critically evaluating current healthcare policies.
Big Pharma's influence persists in healthcare decisions and FDA regulations.
This influence poses risks to public health and innovation in treatments.
Misinformation from authorities can result in wrongful indictments in healthcare.
This highlights the importance of accurate data for legal and medical practices.
The FDA's regulation of peptides can restrict innovation and patient access.
Understanding these regulations is crucial for advocating for patients' rights and needs.
The FDA's infrequent inspections of drug manufacturing facilities are concerning.
This raises questions about drug safety and efficacy in the market.
Watch the full episode of #2079 - Brigham Buhler.
Episode Timestamps
Exploring Big Pharma's Influence on Healthcare and History
- Discussion highlights historical misconduct by pharmaceutical companies affecting public health.
- Concerns raised over the FDA's relationship with Big Pharma and healthcare policies.
- Link established between past atrocities and current healthcare practices involving peptides.
Concerns Over FDA and DOJ's Impact on Healthcare Practices
- Bad information can lead to serious consequences for healthcare professionals and patients.
- The FDA's decisions on peptides may hinder access to important medications.
- Insurance companies and the DOJ create a climate of fear within the healthcare system.
Concerns Over FDA and Big Pharma Accountability
- FDA inspections of Big Pharma facilities are alarmingly infrequent and insufficient.
- Allegations of misconduct and manipulation by pharmaceutical companies raise serious ethical questions.
- Long-form media like podcasts is essential for disseminating critical health information.
Concerns Over Peptide Regulation and Pharmaceutical Oversight
- Peptides like BPC 157 show promise but face potential FDA restrictions.
- Big Pharma's safety misrepresentation could lead to increased black market activity.
- Current healthcare system struggles with transparency and regulatory scrutiny.
Concerns Over Medical Device Safety and Approval Processes
- Majority of surgical products bypass rigorous human safety trials before use.
- FDA's 510K approval process allows unsafe products to enter operating rooms.
- Contamination risks from reused surgical instruments pose serious health threats.
Exploring the Challenges of Alternative Medicine and Insurance
- Discussion on the complexities of stem cell treatments and associated risks.
- Critique of insurance practices affecting access to non-addictive pain treatments.
- Analysis of testosterone therapy misconceptions and its historical context in medicine.
Healthcare Costs and the Role of Pharmacy Benefit Managers
- Pharmacy benefit managers significantly inflate insulin prices, impacting affordability.
- Current insurance models prioritize profit over patient care and root cause solutions.
- Alternative cash pay models may offer more comprehensive healthcare solutions.
Exploring AI's Role in Personalized Medicine and Healthcare Costs
- AI and large language models can transform healthcare accessibility and treatment personalization.
- Proactive, predictive medicine aims to empower patients with informed health decisions.
- Challenges exist in integrating AI with traditional healthcare practices and biases.
Innovations in Primary Care and the Role of Technology
- Discussion of using AI to enhance primary care and patient outcomes.
- Concerns raised over insurance models and their impact on healthcare delivery.
- Personal anecdotes highlight the effectiveness of stem cell treatments and therapies.
Exploring the Benefits and Risks of Emerging Health Technologies
- Red light therapy shows promise in treating various health conditions.
- Insurance companies may exploit large language models for profit.
- Sunlight exposure significantly influences testosterone levels in both men and women.
Pharmacy Benefit Managers Drive Up Drug Prices and Costs
- Pharmacy benefit managers profit heavily from drug pricing discrepancies and patient costs.
- Insurance companies exploit high co-pays while negotiating rebates with pharmaceutical companies.
- Independent pharmacies struggle to survive against major conglomerates and insurance models.
Exploring the Financial Incentives in Healthcare and Preventive Medicine
- Financial incentives in oncology drive treatment decisions and patient outcomes.
- Proactive health measures can significantly reduce chronic disease risk.
- AI and advanced testing can transform personalized medicine and patient care.
Exploring Brain Health and Optimization Techniques for Athletes
- Discussion on using AI and brain mapping for cognitive enhancement.
- The significance of optimizing brain function for high-pressure decision-making.
- Integration of psychedelics in research for improving brain performance.
Exploring Advances in Stem Cell Therapy and Its Implications
- Stem cells can differentiate and heal, contrary to some orthopedic beliefs.
- Heterochronic parabiosis showcases cellular rejuvenation between young and old organisms.
- Current orthopedic practices misunderstand the mechanisms behind stem cell treatments.
Innovative Healing Techniques Transforming Sports Medicine
- Discusses the shift from traditional orthopedic surgery to advanced cellular treatments.
- Highlights the success of multidisciplinary approaches in athlete recovery.
- Explores the implications of using young cellular materials for joint health.
Exploring Alternative Treatments in Sports Medicine
- Discussion on cellular treatments and their role in healing injuries effectively.
- Aaron Rodgers' recovery process highlighted the importance of innovative techniques.
- Critique of traditional orthopedic views and the medical establishment's resistance to change.
People Mentioned
Eisenhower
Former U.S. President
Robert F. Kennedy Jr.
Activist, Politician
Unnamed Speaker
Healthcare Professional, Entrepreneur
Unknown Speaker
Podcast Host/Guest
Joe
Podcast host
Dr. Morgan Tyler
Urologist
Peter Attia
Health Advocate, Physician
Lex
AI expert
Peter Atiyah
Medical professional
Ian White, PhD
Director at Ansari Stem Cell Institute
Dana White
President of the Ultimate Fighting Championship
Huberman
Researcher, Influencer
Unknown
Healthcare speaker
Russell Brand
Media Personality
David Sinclair
Researcher, Scientist
Ian White
Chief Science Officer
Shane Dorian
Athlete
Tony Hinchcliffe
Comedian
Dr. Bruce Dahmer
Researcher, Psychedelic Researcher
Dr. Kaplan
Medical Professional, Researcher
Dr. Ian White
Chief Science Officer
Aaron Rodgers
NFL Athlete
Aaron Alexander
Fitness Expert, Health Expert
Dr. White
Surgeon/Researcher
Places Mentioned
Houston Zoo
Location
Ohio
State
Panama
Country
Tijuana
City
Books Mentioned
Bottle Lies
Unknown Author
Notable Quotes
"would argue that's 100% we've seen."
Discussing the impact of Big Pharma on healthcare innovation.
"Eisenhower warned American people medical industrial complex."
Referring to Eisenhower's warnings about the influence of private industry.
"I’m saying say DOJ bad. think they’re bad all. think they’re given bad information."
Discussion about the DOJ's role in healthcare-related indictments.
"It’s, again, safe drug. even drug. Again, peptide."
Talking about the safety of certain peptides and the FDA's classification.
"We've interacted four times in 18 months."
Discussing the FDA's oversight of pharmaceutical companies.